Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Biomarker Consortium
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center
home
Articles
Rapid Readouts: Phase 2 JULIET Trial
January 26th 2021
Ongoing Issues in CAR T-Cell Therapy and Lymphoma
July 2nd 2020
Developing CAR T-Cell Trials
July 2nd 2020
Allogenic CAR T-Cell Therapy in Lymphoma
July 2nd 2020
CAR T-Cell Therapy’s Future for Lymphoma
July 2nd 2020
CAR T Cells and Lymphoma Adverse Events
July 2nd 2020
LBCL Therapy: The Right Therapy
July 2nd 2020
R/R NHL: Candidate Identification and Referrals
July 2nd 2020
CAR T-Cell Therapy for Follicular Lymphoma
July 2nd 2020
ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact
July 2nd 2020
LDH and ECOG Performance Tests
July 2nd 2020
Liso-cel Therapy in R/R Large B-Cell Lymphoma
July 2nd 2020
The Importance of Antigen Loss in R/R Disease
July 2nd 2020
R/R Large B-Cell Therapy in Managing Various Lymphomas
July 2nd 2020
CAR T-Cell Therapy in Managing Various Lymphomas
July 2nd 2020
Rationale for Further Development of CAR T-Cell therapy
July 2nd 2020